State Street Corp Ardelyx, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Ardelyx, Inc. stock. As of the latest transaction made, State Street Corp holds 11,592,914 shares of ARDX stock, worth $61.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,592,914

Previous 12,141,850 4.52%

Holding current value

$61.8 Million

Previous $83.7 Million 28.36%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.49 - $6.85 $2.46 Million - $3.76 Million	-548,936 Reduced 4.52%	11,592,914 $59.9 Million
Q3 2024 Nov 14, 2024	BUY	$5.28 - $7.57 $933,445 - $1.34 Million	176,789 Added 1.48%	12,141,850 $83.7 Million
Q2 2024 Aug 14, 2024	SELL	$5.89 - $9.31 $12.5 Million - $19.8 Million	-2,123,965 Reduced 15.08%	11,965,061 $88.7 Million
Q1 2024 May 15, 2024	SELL	$6.05 - $9.74 $18.2 Million - $29.4 Million	-3,013,572 Reduced 17.62%	14,089,026 $103 Million
Q4 2023 Feb 14, 2024	BUY	$3.29 - $6.64 $13.1 Million - $26.4 Million	3,976,602 Added 30.3%	17,102,598 $106 Million
Q3 2023 Nov 14, 2023	SELL	$3.3 - $4.83 $30.7 Million - $45 Million	-9,311,568 Reduced 41.5%	13,125,996 $53.6 Million
Q2 2023 Aug 14, 2023	BUY	$3.23 - $4.95 $23.4 Million - $35.8 Million	7,234,448 Added 47.59%	22,437,564 $76.1 Million
Q1 2023 May 15, 2023	BUY	$2.68 - $4.79 $39 Million - $69.7 Million	14,549,803 Added 2227.08%	15,203,116 $72.8 Million
Q4 2022 Feb 14, 2023	BUY	$1.22 - $2.85 $300,608 - $702,240	246,400 Added 60.55%	653,313 $1.86 Million
Q3 2022 Nov 15, 2022	SELL	$0.59 - $1.44 $43,778 - $106,848	-74,200 Reduced 15.42%	406,913 $484,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $1.17 $839,686 - $1.93 Million	-1,646,444 Reduced 77.39%	481,113 $284,000
Q1 2022 May 16, 2022	BUY	$0.65 - $1.18 $90,664 - $164,591	139,484 Added 7.02%	2,127,557 $2.28 Million
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $25,434 - $50,277	-29,575 Reduced 1.47%	1,988,073 $2.19 Million
Q3 2021 Nov 15, 2021	SELL	$1.27 - $8.17 $5.41 Million - $34.8 Million	-4,263,149 Reduced 67.88%	2,017,648 $2.66 Million
Q2 2021 Aug 16, 2021	BUY	$6.55 - $8.98 $16.5 Million - $22.6 Million	2,515,575 Added 66.81%	6,280,797 $47.6 Million
Q1 2021 May 17, 2021	BUY	$6.1 - $7.69 $8.13 Million - $10.2 Million	1,332,556 Added 54.78%	3,765,222 $24.9 Million
Q4 2020 Feb 16, 2021	SELL	$5.05 - $7.1 $1.25 Million - $1.75 Million	-246,795 Reduced 9.21%	2,432,666 $15.7 Million
Q3 2020 Nov 10, 2020	SELL	$5.25 - $7.08 $2.01 Million - $2.71 Million	-382,089 Reduced 12.48%	2,679,461 $14.1 Million
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $10.3 Million - $15.5 Million	1,908,921 Added 165.61%	3,061,550 $21.2 Million
Q1 2020 May 11, 2020	BUY	$4.35 - $8.79 $5.01 Million - $10.1 Million	1,152,629 New	1,152,629 $6.55 Million

Others Institutions Holding ARDX

# of Institutions

233

Shares Held

150M

Call Options Held

1.54M

Put Options Held

3.08M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $824M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Ardelyx, Inc. Transaction History